Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-39601
Neurochem Res 2009 Oct 01;3410:1704-11. doi: 10.1007/s11064-009-9968-x.
Show Gene links Show Anatomy links

Guanidino acids act as rho1 GABA(C) receptor antagonists.

Chebib M , Gavande N , Wong KY , Park A , Premoli I , Mewett KN , Allan RD , Duke RK , Johnston GA , Hanrahan JR .


???displayArticle.abstract???
GABA(C) receptors play a role in myopia, memory-related disorders and circadian rhythms signifying a need to develop potent and selective agents for this class of receptors. Guanidino analogs related to glycine, beta-alanine and taurine were evaluated at human rho(1)GABA(C) receptors expressed in Xenopus oocytes using 2-electrode voltage clamp methods. Of the 12 analogs tested, 8 analogs were active as antagonists and the remaining were inactive. (S)-2-guanidinopropionic acid (IC(50) = 2.2 microM) and guanidinoacetic acid (IC(50) = 5.4 microM; K (B) = 7.75 microM [pK (B) = 5.11 +/- 0.06]) were the most potent being competitive antagonists at this receptor. In contrast, the beta-alanine and GABA guanidino analogs showed reduced activity, indicating the distance between the carboxyl carbon and terminal nitrogen of the guanidino group is critical for activity. Substituting the C2-position of guanidinoacetic acid with various alkyl groups reduced activity indicating that steric effects may impact on activity. The results of this study contribute to the structure-activity-relationship profile required in developing novel therapeutic agents.

???displayArticle.pubmedLink??? 19387831
???displayArticle.link??? Neurochem Res



References [+] :
ARUNLAKSHANA, Some quantitative uses of drug antagonists. 1959, Pubmed